451 related articles for article (PubMed ID: 28758929)
1. Adipokines and Non-Alcoholic Fatty Liver Disease: Multiple Interactions.
Adolph TE; Grander C; Grabherr F; Tilg H
Int J Mol Sci; 2017 Jul; 18(8):. PubMed ID: 28758929
[TBL] [Abstract][Full Text] [Related]
2. Association of Adipose Tissue and Adipokines with Development of Obesity-Induced Liver Cancer.
Rajesh Y; Sarkar D
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671547
[TBL] [Abstract][Full Text] [Related]
3. NAFLD Related-HCC: The Relationship with Metabolic Disorders.
Zhang X
Adv Exp Med Biol; 2018; 1061():55-62. PubMed ID: 29956206
[TBL] [Abstract][Full Text] [Related]
4. Obesity, adipokines and hepatocellular carcinoma.
Duan XF; Tang P; Li Q; Yu ZT
Int J Cancer; 2013 Oct; 133(8):1776-83. PubMed ID: 23404222
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease and hepatocellular carcinoma.
Zoller H; Tilg H
Metabolism; 2016 Aug; 65(8):1151-60. PubMed ID: 26907206
[TBL] [Abstract][Full Text] [Related]
6. Adipocytokines and hepatocellular carcinoma.
Wieser V; Moschen AR; Tilg H
Dig Dis; 2012; 30(5):508-13. PubMed ID: 23108307
[TBL] [Abstract][Full Text] [Related]
7. Roles of Adipokines in Digestive Diseases: Markers of Inflammation, Metabolic Alteration and Disease Progression.
Chang ML; Yang Z; Yang SS
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33167521
[TBL] [Abstract][Full Text] [Related]
8. Adipokines in nonalcoholic fatty liver disease.
Polyzos SA; Kountouras J; Mantzoros CS
Metabolism; 2016 Aug; 65(8):1062-79. PubMed ID: 26725002
[TBL] [Abstract][Full Text] [Related]
9. Down-regulation of microRNA-375 regulates adipokines and inhibits inflammatory cytokines by targeting AdipoR2 in non-alcoholic fatty liver disease.
Lei L; Zhou C; Yang X; Li L
Clin Exp Pharmacol Physiol; 2018 Aug; 45(8):819-831. PubMed ID: 29569260
[TBL] [Abstract][Full Text] [Related]
10. Synergism of Adipocytokine Profile and
Divella R; Daniele A; DE Luca R; Mazzocca A; Ruggieri E; Savino E; Casamassima P; Simone M; Sabba C; Paradiso A
Cancer Genomics Proteomics; 2019; 16(6):519-530. PubMed ID: 31659105
[TBL] [Abstract][Full Text] [Related]
11. Peroxisomal β-oxidation regulates whole body metabolism, inflammatory vigor, and pathogenesis of nonalcoholic fatty liver disease.
Moreno-Fernandez ME; Giles DA; Stankiewicz TE; Sheridan R; Karns R; Cappelletti M; Lampe K; Mukherjee R; Sina C; Sallese A; Bridges JP; Hogan SP; Aronow BJ; Hoebe K; Divanovic S
JCI Insight; 2018 Mar; 3(6):. PubMed ID: 29563328
[TBL] [Abstract][Full Text] [Related]
12. Autophagy, NAFLD and NAFLD-Related HCC.
Wu WKK; Zhang L; Chan MTV
Adv Exp Med Biol; 2018; 1061():127-138. PubMed ID: 29956211
[TBL] [Abstract][Full Text] [Related]
13. NAFLD-related HCC.
Banini BA; Sanyal AJ
Adv Cancer Res; 2021; 149():143-169. PubMed ID: 33579423
[TBL] [Abstract][Full Text] [Related]
14. Insights into the Role of PPARβ/δ in NAFLD.
Chen J; Montagner A; Tan NS; Wahli W
Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29954129
[TBL] [Abstract][Full Text] [Related]
15. Emerging metabolic risk factors in hepatocellular carcinoma and their influence on the liver microenvironment.
Agosti P; Sabbà C; Mazzocca A
Biochim Biophys Acta Mol Basis Dis; 2018 Feb; 1864(2):607-617. PubMed ID: 29197664
[TBL] [Abstract][Full Text] [Related]
16. Adiponectin and PPAR: a setup for intricate crosstalk between obesity and non-alcoholic fatty liver disease.
Ishtiaq SM; Rashid H; Hussain Z; Arshad MI; Khan JA
Rev Endocr Metab Disord; 2019 Sep; 20(3):253-261. PubMed ID: 31656991
[TBL] [Abstract][Full Text] [Related]
17. Obesity, Nonalcoholic Fatty Liver Disease and Adipocytokines Network in Promotion of Cancer.
Divella R; Mazzocca A; Daniele A; Sabbà C; Paradiso A
Int J Biol Sci; 2019; 15(3):610-616. PubMed ID: 30745847
[TBL] [Abstract][Full Text] [Related]
18. Association of Adipokines with Development and Progression of Nonalcoholic Fatty Liver Disease.
Boutari C; Perakakis N; Mantzoros CS
Endocrinol Metab (Seoul); 2018 Mar; 33(1):33-43. PubMed ID: 29589386
[TBL] [Abstract][Full Text] [Related]
19. Adipocyte cell size, free fatty acids and apolipoproteins are associated with non-alcoholic liver injury progression in severely obese patients.
Wree A; Schlattjan M; Bechmann LP; Claudel T; Sowa JP; Stojakovic T; Scharnagl H; Köfeler H; Baba HA; Gerken G; Feldstein AE; Trauner M; Canbay A
Metabolism; 2014 Dec; 63(12):1542-52. PubMed ID: 25267016
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology and Etiologic Associations of Non-alcoholic Fatty Liver Disease and Associated HCC.
Liu K; McCaughan GW
Adv Exp Med Biol; 2018; 1061():3-18. PubMed ID: 29956203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
